Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory prophylaxis after cataract surgery
2017-002666-47Phase 4Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ketorolac, prednisolone and dexamethasone sodium phosphate in cystoid macular edema (CME) and Irvine-Gass syndrome (IGS) (3 arms), sponsored by Rigshospitalet Glostrup. Primary endpoint: Change in central macular thickness. Started Jun 2017; status: completed.
02
Drugs
ketorolacprednisolonedexamethasone sodium phosphate
03
Conditions
cystoid macular edema (CME)Irvine-Gass syndrome (IGS)
Beyond the preview
Go deeper on 2017-002666-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002666-47.